New AI-Powered Free Company Valuation tool for any company in the world. Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics. Try Now for Free →
- Get an AI-powered company valuation or credit risk report in just 2 minutes
- Get reports of any company in the world with a financial statement in any language
- Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics
ASCENDIS PHARMA A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About ASCENDIS PHARMA A/S
ASCENDIS PHARMA A/S (CVR number: 29918791K) is a company from GENTOFTE. The company reported a net sales of 720.1 mEUR in 2025, demonstrating a growth of 98 % compared to the previous year. The operating profit percentage was poor at -18.9 % (EBIT: -136.3 mEUR), while net earnings were -228 mEUR. The profitability of the company measured by Return on Assets (ROA) was -0.4 %, which can be considered poor and Return on Equity (ROE) was -18.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -11.1 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ASCENDIS PHARMA A/S's liquidity measured by quick ratio was 0.8 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsNet sales (mEUR)
EBIT (mEUR)
Profitability
Solidity
Key figures (mEUR)
See financials2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Volume | |||||
| Net sales | 7.78 | 51.17 | 266.72 | 363.64 | 720.13 |
| Gross profit | 4.25 | 39.04 | 222.32 | 319.38 | 625.22 |
| EBIT | - 451.79 | - 561.81 | - 455.54 | - 278.76 | - 136.27 |
| Net earnings | - 383.58 | - 583.19 | - 481.45 | - 378.08 | - 228.03 |
| Shareholders equity total | 883.63 | 263.35 | - 145.70 | - 105.71 | - 162.82 |
| Balance sheet total (assets) | 1 084.92 | 1 089.74 | 825.59 | 1 179.49 | 1 302.57 |
| Net debt | - 341.31 | -45.58 | - 154.99 | - 161.13 | - 173.65 |
| Profitability | |||||
| EBIT-% | -5808.6 % | -1097.9 % | -170.8 % | -76.7 % | -18.9 % |
| ROA | -36.8 % | -48.5 % | -41.7 % | -24.2 % | -0.4 % |
| ROE | -44.5 % | -101.7 % | -88.4 % | -37.7 % | -18.4 % |
| ROI | -39.5 % | -54.3 % | -70.1 % | -70.2 % | -1.1 % |
| Economic value added (EVA) | - 498.14 | - 616.88 | - 501.62 | - 287.18 | - 160.13 |
| Solvency | |||||
| Equity ratio | 81.4 % | 24.2 % | -15.0 % | -8.2 % | -11.1 % |
| Gearing | 11.9 % | 151.6 % | -162.8 % | -376.9 % | -271.7 % |
| Relative net indebtedness % | -3149.7 % | 745.7 % | 217.1 % | 199.6 % | 117.9 % |
| Liquidity | |||||
| Quick ratio | 7.3 | 4.6 | 0.7 | 0.8 | 0.8 |
| Current ratio | 8.0 | 5.4 | 1.0 | 1.2 | 1.0 |
| Cash and cash equivalents | 446.27 | 444.77 | 392.16 | 559.54 | 616.04 |
| Capital use efficiency | |||||
| Trade debtors turnover (days) | 103.2 | 84.9 | 49.1 | 166.9 | 71.6 |
| Net working capital % | 9070.8 % | 1469.9 % | -12.7 % | 42.1 % | 5.5 % |
| Credit risk | |||||
| Credit rating | BBB | BB | BB | BB | BB |
Variable visualization
Roles
Companies in the same industry
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.